GlassScriptPhysician profile
Jessica Spinelli
NPI 1205511417
$4,218.52
in general payments reported to CMS, 2019-2025
23 companies · $2,638 in 2025
The $2,638 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $206 · 2024: $1,374 · 2025: $2,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,218.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $576.87 | 2024-2025 | |
| Incyte Corporation | $565.44 | 2024-2025 | Opzelura, Opzelura |
| Galderma Laboratories, L.P. | $476.08 | 2024-2025 | Aklief, Nemluvio |
| Dermavant Sciences, INC. | $348.45 | 2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $328.11 | 2024-2025 | |
| Lilly USA, LLC | $299.57 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Amgen INC. | $274.33 | 2024-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $241.05 | 2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $221.35 | 2024-2025 | Dupixent |
| Organon LLC | $184.96 | 2025 | Vtama |
| Journey Medical Corporation | $174.79 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $166.70 | 2024-2025 | Sotyktu |
| Verrica Pharmaceuticals INC. | $118.24 | 2023 | Ycanth |
| Ucb, INC. | $51.01 | 2024-2025 | Bimzelx |
| Mayne Pharma Commercial LLC | $39.12 | 2023-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $29.74 | 2023-2024 | Tremfya |
| Convatec INC. | $24.58 | 2023 | |
| Strata Skin Sciences, INC. | $19.92 | 2024 | Xtrac |
| Sun Pharmaceutical Industries INC. | $18.00 | 2024 | |
| Botanix Sb INC | $15.72 | 2025 | Sofdra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.16 | 2023 | Jublia, Duobrii, Arazlo |
| Biofrontera INC. | $15.00 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Lnhc, INC | $14.33 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Spinelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.